Dashboard
Manage Tickers

EVOK


   

CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ ()
DIA ()
SPY ()
TLT ()
GLD ()
$ na
-- x --
-- x --
-- - --
-- - --
--
na
--
--
--
TBD
--
-- (--)
--
TBD --
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

evoke-pharma-and-eversana-expand-gimoti-access-through-omnicell-partnership-with-gastro-health-and-large-gi-practices-add-onegi-via-brentwood-pharmacy-nearly-doubling-specialty-pharmacy-network
Evoke Pharma And EVERSANA Expand GIMOTI® A...
08/26/2025 11:12:26

Core News & Articles
12 Health Care Stocks Moving In Friday's A...
08/22/2025 21:07:35

Core News & Articles
12 Health Care Stocks Moving In Friday's P...
08/22/2025 12:08:33

Core News & Articles
12 Health Care Stocks Moving In Thursday's...
08/21/2025 21:06:06

5-healthcare-stocks-on-fire-this-week
5 Healthcare Stocks On Fire This Week
08/21/2025 12:24:39

Healthcare stocks SNOA, EVOK, KALA, DNA, & SNGX soar with massive momentum gains, signaling breakout potential in biotech &...

Core News & Articles
12 Health Care Stocks Moving In Thursday's...
08/21/2025 12:08:08

Core News & Articles
Market-Moving News for August 21st
08/21/2025 11:22:02

WMT: -4% | Walmart shares are trading lower following mixed Q2 financial results. APM: 69% | DiamiR's APOE Genotyping Test ...

evoke-pharma-highlights-newly-listed-us-patent-for-gimoti-in-fda-orange-book-with-expiration-date-of-november-17-2038
Evoke Pharma Highlights Newly Listed US Pa...
08/21/2025 11:07:16

evoke-pharma-q2-eps-062-misses-030-estimate-sales-3752m-miss-3796m-estimate
Evoke Pharma Q2 EPS $(0.62) Misses $(0.30)...
08/14/2025 11:04:13

Evoke Pharma (NASDAQ:EVOK) reported quarterly losses of $(0.62) per share which missed the analyst consensus estimate of $(0.30...

evoke-pharma-secures-new-us-patent-for-gimoti-nasal-spray-targeting-moderate-to-severe-gastroparesis
Evoke Pharma Secures New U.S. Patent For G...
08/06/2025 10:37:18

Evoke Pharma, Inc. (NASDAQ:EVOK), a specialty pharmaceutical company focused primarily on treatments for gastrointestinal (GI) ...

crude-oil-moves-higher-rxsight-shares-plunge
Crude Oil Moves Higher; RxSight Shares Plunge
07/09/2025 17:33:45

Core News & Articles
12 Health Care Stocks Moving In Wednesday'...
07/09/2025 17:06:52

evoke-pharma-evok-shares-skyrocket-on-new-patent-whats-going-on
Evoke Pharma (EVOK) Shares Skyrocket On Ne...
07/09/2025 15:15:02

Shares of Evoke Pharma are trading sharply higher Wednesday morning. The specialty pharma company received a U.S. Patent Office...

dow-jumps-200-points-us-wholesale-inventories-fall-03-in-may
Dow Jumps 200 Points; US Wholesale Invento...
07/09/2025 14:36:55

evoke-pharma-receives-notice-of-allowance-from-uspto-for-us-patent-application-covering-use-of-gimoti-in-patients-with-moderate-to-severe-symptoms-of-gastroparesis
Evoke Pharma Receives Notice Of Allowance ...
07/09/2025 12:18:45

Evoke Pharma, Inc. (NASDAQ:EVOK), a specialty pharmaceutical company focused primarily on treatments for gastrointestinal (GI) ...

Core News & Articles
12 Health Care Stocks Moving In Friday's I...
06/06/2025 17:06:47

evoke-pharma-q1-eps-051-misses-033-estimate-sales-308m-miss-332m-estimate
Evoke Pharma Q1 EPS $(0.51) Misses $(0.33)...
05/13/2025 20:35:06

Evoke Pharma (NASDAQ:EVOK) reported quarterly losses of $(0.51) per share which missed the analyst consensus estimate of $(0.33...

Core News & Articles
12 Health Care Stocks Moving In Tuesday's ...
05/06/2025 21:06:18

12-health-care-stocks-moving-in-mondays-after-market-session
12 Health Care Stocks Moving In Monday's A...
03/31/2025 21:05:46

evoke-pharma-q4-sales-331m-beat-308m-estimate
Evoke Pharma Q4 Sales $3.31M Beat $3.08M E...
03/13/2025 20:14:05

Evoke Pharma (NASDAQ:EVOK) reported quarterly sales of $3.31 million which beat the analyst consensus estimate of $3.08 million...

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION